AFAIK RAC isn't going to test bisantrene on prostate cancer.
If you mean the risk that bisantrene might worsen the disease in say breast cancer, that's extremely low because of the historical trials and the preclinicals.
AFAIK RAC isn't going to test bisantrene on prostate...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.040(2.42%) |
Mkt cap ! $274.2M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.70 | $1.60 | $229.6K | 139.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 129 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 2839 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |